Castle Biosciences
CSTL
CSTL
144 hedge funds and large institutions have $674M invested in Castle Biosciences in 2020 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 63 increasing their positions, 36 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
14% more funds holding
Funds holding: 126 → 144 (+18)
7.67% more ownership
Funds ownership: 60.68% → 68.35% (+7.7%)
99% less call options, than puts
Call options by funds: $5K | Put options by funds: $791K
Holders
144
Holding in Top 10
4
Calls
$5K
Puts
$791K
Top Buyers
| 1 | +$14.8M | |
| 2 | +$14.7M | |
| 3 | +$12.6M | |
| 4 |
BlackRock
New York
|
+$9.14M |
| 5 |
Goldman Sachs
New York
|
+$5.88M |
Top Sellers
| 1 | -$13.5M | |
| 2 | -$6.43M | |
| 3 | -$5.65M | |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$3.77M |
| 5 |
RI
RTW Investments
New York
|
-$3.08M |